 - Those patients initiated on rivaroxaban after the second follow-up will be called in for a third clinical and imaging follow-up, with focus on leaflet morphology andor motion after rivaroxaban therapy. In case of persistent abnormal leaflet morphology andor motion despite NOAC, a treatment with Marevan INR 2-3 will be initiated. 